Clinical Trials Logo
NCT number NCT03495674
Study type Interventional
Source M.D. Anderson Cancer Center
Contact Susan Gilchrist, MD
Phone 713-745-6251
Status Recruiting
Phase N/A
Start date April 4, 2018
Completion date March 2021

Clinical Trial Summary

The goal of this research study is to learn if sustained exercise can affect the outcomes in patients with a specific type of colorectal cancer called Lynch Syndrome .

This is an investigational study.

Up to 20 participants will be enrolled in this study. All will take part at MD Anderson and in the local community.

Clinical Trial Description

If you agree to take part in this study, you will be asked screening questions to complete the eligibility requirement and if you are eligible you will have the following study visits.

Study Visits:

Visit 1 (Day 0):

- You will have a lower GI endoscopy (flexible sigmoidoscopy or colonoscopy). During an endoscopy, you will be mildly sedated and a thin, flexible tube (called an endoscope) will be inserted inside the anus, rectum, and colon. Tissue samples will also be collected during this procedure. Up to 15 normal tissue biopsies will be taken during these procedures for biomarker testing, including genetic biomarkers. Biomarkers are found in the blood/tissue and may be related to the disease and the impact of exercise on the disease. If the doctor finds any abnormal tissue in your bowel during the procedure, they will be counted and removed. You will sign a separate consent for this procedure which will describe it in more detail, including its risks.

- Blood (about 1 teaspoon) and urine will be collected for biomarker testing. You must fast (have nothing to eat or drink except water) for at least 12 hours before each blood draw as part of this study.

Visit 2 (Day 15):

- You will have a cardiopulmonary exercise test (CPET) to check your lung function. The CPET checks how well your lungs are working by measuring how much oxygen and carbon dioxide your lungs take in and release when you breathe. To perform this test, you will be asked to bicycle at increasingly higher resistance until you reach a point that you can no longer exercise. You will be breathing into the machine while you cycle. This test will take about 30 minutes to complete. The study doctor and an exercise physiologist will be present for each CPET and available to respond to any complication.

- You will have an EKG to check your heart function.

- You will complete a questionnaire about your demographics, health history, and physical activity.

Cycling Classes and FITBIT:

Starting at Day 15 of the study, you will enroll in 3 cycling classes every week (for a total of 12 cycling classes each month). You will continue with these classes for up to 1 year. These cycling classes can be done at any fitness center in your local community. You will not be responsible for the cost of these cycling classes. You may choose any cycling class at any location you prefer.

You will be given a FITBIT to wear while you attend cycling classes. You are encouraged to wear the FITBIT during the day as well, but this is not required. The FITBIT will record your exercise frequency and intensity. The exercise physiologist will tell you how to use it, if you have any questions. The FITBIT will be yours to keep. Data from your FITBIT will be linked to your medical record.

After Day 15, you will be contacted, either phone or email, every 2 weeks by the study staff and asked about your FITBIT and FITBIT data and your exercise schedule. The exercise physiologist will discuss any barriers to exercise you may be having and/or answer any questions you may have related to physical activity, including the cycling classes.

Visit 3 (between Day 300-360):

- You will have a physical exam.

- You will have an endoscopy as described above in Visit 1.

- Blood (about 1 teaspoon) and urine will be collected for biomarker testing.

Visit 4 (within 30 days after Visit 3):

- You will have a CPET to check your heart and lung function.

- You will also complete the questionnaires about your demographics, health history, and physical activity.

Length of Study:

Your active participation in this study will be over after Visit 4. If you continue to use the FITBIT after your participation in this study is over, the data will not be viewed, collected, or entered into your medical record.

Study Design

Related Conditions & MeSH terms

See also
  Status Clinical Trial Phase
Completed NCT00905710 - Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome N/A
Recruiting NCT02912559 - Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Phase 3
Not yet recruiting NCT03047226 - Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer N/A
Not yet recruiting NCT03046849 - Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria N/A
Active, not recruiting NCT01845753 - Molecular Screening for Lynch Syndrome in Denmark
Completed NCT01216930 - Molecular Screening for Lynch Syndrome in Southern Denmark N/A
Recruiting NCT02570516 - NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome N/A
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research N/A
Completed NCT01823471 - I-Scan For Colon Polyp Detection In HNPCC N/A
Recruiting NCT02813824 - Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome Phase 3
Recruiting NCT02359565 - Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, or Hypermutated Brain Tumors Phase 1
Completed NCT00898768 - Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome Phase 0
Recruiting NCT00508573 - Registry for Women Who Are At Risk Or May Have Lynch Syndrome N/A
Enrolling by invitation NCT03460483 - Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care N/A
Completed NCT02951390 - High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome. N/A
Recruiting NCT02494791 - Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer N/A
Recruiting NCT02198092 - Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes N/A
Recruiting NCT03303833 - The GEOLynch Cohort Study N/A
Active, not recruiting NCT02052908 - Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome Phase 1
Not yet recruiting NCT01199250 - Biomarkers in Samples From Patients With Endometrial Cancer N/A